Search research articles
Contact Us
Filters
Showing results (281-290 of 308) with videos related to
Page
of 31
Sort By:
Cell Reports
|
February 9, 2022
Follicular T cells optimize the germinal center response to SARS-CoV-2 protein vaccination in mice
Cecilia B Cavazzoni, Benjamin L Hanson, Manuel A Podestà, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 30, 2019
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC
Silvia La Monica, Roberta Minari, Daniele Cretella, et al.
Neoplasia (New York, N.Y.)
|
July 14, 2017
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells
Mara A Bonelli, Graziana Digiacomo, Claudia Fumarola, et al.
Cancer Chemotherapy and Pharmacology
|
November 22, 2013
Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinib
Marcello Tiseo, Massimo Ippolito, Maura Scarlattei, et al.
Breast Cancer Research and Treatment
|
January 8, 2010
Synergistic activity of letrozole and sorafenib on breast cancer cells
Mara A Bonelli, Claudia Fumarola, Roberta R Alfieri, et al.
Nature Communications
|
March 4, 2025
Follicular regulatory T cells restrain kidney allograft rejection in mice by suppressing alloreactive B cells
Hengcheng Zhang, Manuel A Podestà, Cecilia B Cavazzoni, et al.
Scientific Reports
|
March 19, 2024
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models
Silvia La Monica, Federica Vacondio, Kamal Eltayeb, et al.
Molecular Cancer
|
December 14, 2012
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines
Andrea Cavazzoni, Roberta R Alfieri, Daniele Cretella, et al.
Oncotarget
|
September 9, 2017
Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN
Andrea Cavazzoni, Silvia La Monica, Roberta Alfieri, et al.
Immunobiology
|
November 21, 2019
B-1 lymphocytes are able to produce IL-10, but is not pathogenic during Leishmania (Leishmania) amazonensis infection
Luan Firmino-Cruz, Tadeu Diniz Ramos, Alessandra Marcia da Fonseca-Martins, et al.
Page
of 31
Search research articles
Search
Showing results (281-290 of 308) with videos related to
Sort By:
Page
of 31
Cell Reports
|
February 9, 2022
Follicular T cells optimize the germinal center response to SARS-CoV-2 protein vaccination in mice
Cecilia B Cavazzoni, Benjamin L Hanson, Manuel A Podestà, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 30, 2019
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC
Silvia La Monica, Roberta Minari, Daniele Cretella, et al.
Neoplasia (New York, N.Y.)
|
July 14, 2017
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells
Mara A Bonelli, Graziana Digiacomo, Claudia Fumarola, et al.
Cancer Chemotherapy and Pharmacology
|
November 22, 2013
Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinib
Marcello Tiseo, Massimo Ippolito, Maura Scarlattei, et al.
Breast Cancer Research and Treatment
|
January 8, 2010
Synergistic activity of letrozole and sorafenib on breast cancer cells
Mara A Bonelli, Claudia Fumarola, Roberta R Alfieri, et al.
Nature Communications
|
March 4, 2025
Follicular regulatory T cells restrain kidney allograft rejection in mice by suppressing alloreactive B cells
Hengcheng Zhang, Manuel A Podestà, Cecilia B Cavazzoni, et al.
Scientific Reports
|
March 19, 2024
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models
Silvia La Monica, Federica Vacondio, Kamal Eltayeb, et al.
Molecular Cancer
|
December 14, 2012
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines
Andrea Cavazzoni, Roberta R Alfieri, Daniele Cretella, et al.
Oncotarget
|
September 9, 2017
Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN
Andrea Cavazzoni, Silvia La Monica, Roberta Alfieri, et al.
Immunobiology
|
November 21, 2019
B-1 lymphocytes are able to produce IL-10, but is not pathogenic during Leishmania (Leishmania) amazonensis infection
Luan Firmino-Cruz, Tadeu Diniz Ramos, Alessandra Marcia da Fonseca-Martins, et al.
Page
of 31